[Federal Register Volume 82, Number 192 (Thursday, October 5, 2017)]
[Notices]
[Pages 46511-46512]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-21503]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


``Partnering to Prevent Hypoglycemia'' Listening Session

AGENCY: Office of Disease Prevention and Health Promotion, Office of 
the Secretary, U.S. Department of Health and Human Services.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Office of Disease Prevention and Health Promotion (ODPHP) 
is hosting a listening session titled, ``Partnering to Prevent 
Hypoglycemia.'' The purpose of this

[[Page 46512]]

listening session is to exchange information about the public health 
importance of hypoglycemia, and discuss federal efforts to reduce 
preventable hypoglycemia from diabetes medications. The Department of 
Health and Human Services invites public and private professionals, 
organizations, and consumer representatives to register to attend this 
listening session at https://health.gov/news/.

DATES: The public listening session will be held on November 1, 2017, 
from 9:00 a.m. to 4:00 p.m. EDT.

ADDRESSES: The meeting will only be accessible by attendance in-person. 
For in-person participants, the meeting will take place in the Hubert 
H. Humphrey Building, Room 800, 200 Independence Ave. SW., Washington, 
DC 20201.

FOR FURTHER INFORMATION CONTACT: Ndome Essoka, Health Policy Fellow, 
Office of Disease Prevention and Health Promotion, Office of the 
Assistant Secretary for Health, U.S. Department of Health and Human 
Services, 1101 Wootton Parkway, Suite LL100, Rockville, MD 20852, 
phone: 240-453-8217, email: <a href="/cdn-cgi/l/email-protection#bcd2d8d3d1d992d9cfcfd3d7ddfcd4d4cf92dbd3ca"><span class="__cf_email__" data-cfemail="28464c47454d064d5b5b4743496840405b064f475e">[email protected]</span></a> or <a href="/cdn-cgi/l/email-protection#044b4c55446c6c772a636b72"><span class="__cf_email__" data-cfemail="d49b9c8594bcbca7fab3bba2">[email protected]</span></a> (please 
indicate in the subject line: Partnering to Prevent Hypoglycemia).

SUPPLEMENTARY INFORMATION: In September 2012, in response to heightened 
awareness of the contribution of adverse drug events (ADEs) to the 
burden of health care-related harm and costs, the Office of the 
Assistant Secretary for Health (OASH) marshaled the wide-ranging and 
diverse resources of federal partners to form an extensive interagency 
partnership, the Federal Interagency Steering Committee and Workgroups 
for Adverse Drug Events, whose goals would be to develop the ADE Action 
Plan, as well as identify measures to track national progress in 
reducing ADEs and targets to meet based on those measures.
    ODPHP, in conjunction with the Federal Interagency Steering 
Committee and three Federal Interagency Workgroups, developed and 
released the final ADE Action Plan in 2014. The ADE Action Plan seeks 
to engage all stakeholders in coordinated efforts to reduce ADEs that 
are not only clinically significant but largely preventable. Inpatient 
and outpatient use of anticoagulants, diabetes agents, and opioid 
analgesics (with specific focus on ADEs from therapeutic use of 
opioids) contribute to the reason why ADEs account for the greatest 
number of measurable harms. The ADE Action Plan identifies the federal 
government's highest priority strategies and opportunities for 
advancement, which will have the greatest impact on reducing ADEs. 
Implementation of these strategies is expected to result in safer and 
higher quality health care services, reduced health care costs, 
informed and engaged consumers and, ultimately, improved health 
outcomes. For more information on the ADE Action Plan, visit https://health.gov/hcq/ade-action-plan.asp.
    Purpose of the Meeting: ODPHP is hosting a listening session 
titled, ``Reducing Preventable Hypoglycemia.'' The purpose of this 
listening session is to exchange information about the public health 
importance of hypoglycemia, and discuss federal efforts to reduce 
preventable hypoglycemia from diabetes medications. This information 
may assist ODPHP and federal partners in identifying how patients and 
providers are affected by hypoglycemia, where gaps in knowledge exist, 
and how information can be better disseminated.
    Meeting Registration: There is no registration fee to attend the 
public listening session. Early registration is recommended because 
seating is limited, and registration will be on a first-come, first-
served basis. There will be no onsite registration. Persons interested 
in attending this listening session must register online at https://health.gov/news/. For those without Internet access, please contact 
Ndome Essoka (see FOR FURTHER INFORMATION CONTACT) to register. If you 
need special accommodations due to a disability, please contact Ndome 
Essoka at least seven days in advance.

    Dated: September 29, 2017.
Don Wright,
Deputy Assistant Secretary for Health (Disease Prevention and Health 
Promotion).
[FR Doc. 2017-21503 Filed 10-4-17; 8:45 am]
 BILLING CODE 4150-32-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>